Articleresearch

Intermittent Fasting Reduces Inflammation Markers Across 21 Studies: What the Research Shows

A 2025 network meta-analysis in Nutrients pooled 839 adults across 21 trials and found IF significantly reduced TNF-alpha, CRP, and leptin — with time-restricted feeding showing the largest effect.

FastingInPractice Editors

Intermittent Fasting Reduces Inflammation Markers Across 21 Studies: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

TitleThe Effects of Intermittent Fasting on Inflammatory Markers in Adults: A Systematic Review and Pairwise and Network Meta-Analyses
JournalNutrients
PublishedJuly 2025
Study typeSystematic review with pairwise and network meta-analysis
Total participants839 adults across 21 included trials
Fasting protocols coveredTime-restricted feeding (TRF), alternate-day fasting (ADF), modified fasting, 5:2
Lead researcherMousa Khalafi
InstitutionUniversity of Kashan, Iran
FundingNot reported
SourceView on PubMed Central →

What This Study Looked At

Chronic low-grade inflammation sits at the root of most modern disease — from cardiovascular disease and type 2 diabetes to autoimmune conditions and accelerated aging. Researchers know that diet plays a central role in either driving or reducing this background inflammatory state. But does the timing of eating — not just its content — have independent anti-inflammatory effects?

This 2025 meta-analysis from Khalafi and colleagues set out to answer exactly that. By pooling data from 21 randomized and non-randomized trials, the research team used both standard pairwise meta-analysis and network meta-analysis (a technique that allows direct comparison between different fasting protocols) to measure intermittent fasting's effect on five key inflammatory markers: TNF-alpha, C-reactive protein (CRP), interleukin-6 (IL-6), leptin, and adiponectin. The analysis is one of the most comprehensive assessments to date of how intermittent fasting affects inflammation.


Who Was Studied

GroupTrialsParticipants
Intermittent fasting (various protocols)21 trials839 adults total
Control (unrestricted or ad libitum feeding)Matched comparison groups in each trialIncluded in 839 total

Participant profile: Adult men and women. Studies included participants across the weight spectrum, with many trials enrolling overweight or obese individuals. Age ranges varied by study. Specific health conditions differed across included trials.

How intermittent fasting worked in these studies: Protocols varied across the 21 trials. Time-restricted feeding (TRF) involved eating within a defined daily window (typically 8–10 hours). Alternate-day fasting (ADF) alternated normal eating days with very-low-calorie or fasting days. Modified fasting (5:2 protocol) involved five normal eating days and two very-low-calorie days per week. Intervention duration ranged across studies, with most lasting at least 8 weeks.


What the Researchers Found

TNF-Alpha (Tumor Necrosis Factor-Alpha)

TNF-alpha is a primary driver of systemic inflammation, elevated in obesity, metabolic syndrome, and autoimmune disease.

OutcomeResult
Change in TNF-α with IFSMD −0.31 (p = 0.009) — statistically significant reduction
TRF specificallySMD −0.39 (p = 0.001) — largest reduction among all IF protocols
ADFLower effect (P-score 0.24 vs. TRF's 0.78)
  • Intermittent fasting produced a significant, consistent reduction in TNF-alpha across included trials.
  • Time-restricted feeding outperformed other IF protocols for TNF-alpha reduction, ranking highest (P-score 0.78) in the network meta-analysis.
  • The effect was statistically robust with p = 0.009, meaning the probability the result is due to chance alone is less than 1%.

C-Reactive Protein (CRP)

CRP is the most widely used clinical marker of inflammation, typically measured in blood tests ordered by doctors.

OutcomeResult
Change in CRP with IFSMD −0.19 (p = 0.04) — statistically significant reduction
  • IF produced a statistically significant reduction in CRP, though the effect size was smaller than for TNF-alpha.
  • This finding is clinically meaningful because CRP is the most practically measurable inflammation marker in routine blood work.

Leptin

Leptin is a hormone produced by fat cells that influences hunger signaling — but also drives inflammation when chronically elevated (as it is in obesity).

OutcomeResult
Change in leptin with IFSMD −0.57 (p = 0.005) — the largest effect of any marker measured
  • This was the most robust finding in the meta-analysis. IF produced a substantial, highly significant reduction in leptin — which simultaneously reduces hunger signaling dysfunction and chronic inflammation driven by adipose tissue.

What Did Not Change

  • IL-6 (interleukin-6): No statistically significant reduction with intermittent fasting across included trials
  • Adiponectin: No statistically significant change with intermittent fasting

What the Researchers Concluded

Intermittent fasting is an effective dietary strategy for reducing key inflammatory markers in adults, with meaningful reductions in TNF-alpha, CRP, and leptin. Among the available protocols, time-restricted feeding demonstrated the highest rankings for anti-inflammatory effect, suggesting that when the goal is inflammation reduction, the daily eating window model (TRF) may be more effective than alternate-day or weekly fasting approaches.


What This Means If You Fast

  • Your daily fasting window has direct anti-inflammatory effects. This isn't just about weight loss — the timing of eating itself, independent of calories, reduces inflammatory markers. Sustaining a consistent 16:8 or similar time-restricted protocol appears to be one of the most practical tools for lowering chronic inflammation.

  • TNF-alpha and CRP are the two most clinically actionable findings. If your doctor has flagged elevated CRP or inflammatory markers in your blood work, the data from this meta-analysis suggests an 8-week or longer intermittent fasting practice may produce measurable reductions.

  • TRF outperformed ADF and modified fasting for inflammation. For people specifically targeting inflammation, time-restricted feeding appears to be the better approach — this aligns with what many practitioners report: daily consistency matters more than periodic extreme restriction.

  • Leptin reduction is a particularly significant finding. High leptin (leptin resistance) is associated with weight loss resistance, persistent hunger, and inflammation. The substantial SMD of −0.57 suggests fasting may help restore leptin sensitivity, potentially making hunger signals more accurate and weight management more sustainable. This connects to why intermittent fasting addresses weight loss plateaus for many people.

  • Don't expect IL-6 or adiponectin changes in the short term. These markers appear less responsive to IF in the study timelines analyzed — they may require longer-duration fasting or additional dietary changes (such as reducing ultra-processed foods) to shift.

  • The intervention works regardless of baseline weight. While many studies included overweight participants, the mechanism — reduced insulin, cellular stress response, autophagy activation — applies to people at a range of weights. The inflammatory benefits are not conditional on first losing weight.


Study Limitations

  • This is a meta-analysis of heterogeneous studies — the fasting protocols, durations, and participant characteristics varied significantly across the 21 included trials, making direct comparison imprecise
  • Some included trials were non-randomized, which introduces potential bias not present in true RCTs
  • The 839-participant total is spread across 21 studies — individual studies were relatively small
  • Study durations were not uniformly long enough to capture the full extent of anti-inflammatory adaptation
  • Dietary content of the eating window was not controlled or reported consistently across studies — the overlap between dietary quality and fasting effects cannot be fully separated
  • Most studies enrolled adults with overweight or obesity, limiting generalizability to lean populations
  • Publication bias: positive results are more likely to be published, which can inflate effect size estimates in meta-analyses

Source

Khalafi, M., Habibi Maleki, A., Mojtahedi, S., Ehsanifar, M., Rosenkranz, S. K., Symonds, M. E., Tarashi, M. S., Fatolahi, S., & Fernandez, M. L. (2025). The effects of intermittent fasting on inflammatory markers in adults: A systematic review and pairwise and network meta-analyses. Nutrients, 17(15), 2388. PMC12348594


Frequently Asked Questions

Does intermittent fasting reduce inflammation?

Yes, according to this 2025 meta-analysis of 21 trials and 839 adults. IF significantly reduced TNF-alpha (SMD −0.31, p = 0.009), CRP (SMD −0.19, p = 0.04), and leptin (SMD −0.57, p = 0.005) compared to control groups. IL-6 and adiponectin did not show statistically significant changes.

Which intermittent fasting protocol is best for reducing inflammation?

Based on this network meta-analysis, time-restricted feeding (TRF) — eating within a defined daily window such as 16:8 — ranked highest for TNF-alpha reduction with an SMD of −0.39 (p = 0.001) and a P-score of 0.78. Alternate-day fasting ranked lower (P-score 0.24) for this outcome.

How long does it take for intermittent fasting to reduce CRP?

The trials included in this meta-analysis generally ran for 8 weeks or longer. The significant CRP reduction (SMD −0.19, p = 0.04) suggests measurable changes can emerge within 8–12 weeks of consistent fasting practice, though longer adherence likely produces more durable effects.

What does TNF-alpha have to do with weight and health?

TNF-alpha (tumor necrosis factor-alpha) is a cytokine produced by immune cells and adipose tissue that drives inflammation throughout the body. Chronically elevated TNF-alpha is linked to insulin resistance, cardiovascular disease, metabolic syndrome, and autoimmune flare-ups. A significant reduction (as found here) means the body's background inflammatory signaling has decreased.

Is CRP a reliable way to track whether fasting is working?

CRP is the most accessible inflammatory marker — it's included in standard blood panels ordered by most doctors. A reduction in high-sensitivity CRP (hsCRP) is associated with reduced cardiovascular risk and lower metabolic disease risk. If your doctor checks your CRP and it's elevated, fasting may be one of the most practical interventions to address it.

Does fasting help with conditions driven by inflammation?

Inflammation is a driver of many chronic conditions — arthritis, cardiovascular disease, type 2 diabetes, autoimmune conditions, and metabolic syndrome. Reducing TNF-alpha and CRP through intermittent fasting may help support management of these conditions, but fasting is not a replacement for medical treatment. Always consult your doctor.


Related Research and Articles


Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.

📗

Want the complete guide?

Intermittent Fasting in Practice

Everything in this article — and hundreds more pages of practical guidance, protocols, recipes, and mindset strategies — is covered in depth in the book, available now on Amazon.

💬

Have personal experience with this? Your story helps thousands of people.